CMS Compliance
HOPE replaced HIS on October 1, 2025. Here's what your agency needs to do.
6 min read
Compliance
June 2026 · 6 min read
You scheduled the face-to-face for day 157. Benefit period 3 starts on day 181. Twenty-four days ahead — comfortably within the 30-day window. The hospice physician completed it, made notes, signed the attestation. Done.
Except the ADR comes back with a finding: face-to-face not timely. Why? Because the encounter was documented in the visit notes but the formal attestation wasn't in the record. Or the physician who completed it was the attending, not a hospice physician. Or — and this happens more than you'd think — the wrong benefit period start date was used to calculate the window.
The face-to-face requirement has multiple failure modes, and all of them result in the same outcome: an invalid recertification and a repayment demand.
A face-to-face encounter with a hospice physician or nurse practitioner is required before benefit period 3 and every benefit period after that. Benefit periods 1 and 2 don't require one. BP3 starts on day 181. Every 60-day period after that requires another.
The window: the encounter must occur no more than 30 days before the benefit period start date. A face-to-face on day 140 — 41 days before BP3 begins — is outside the window and doesn't count. The encounter needs to happen between days 151 and 180 for BP3 to be valid. After the period starts, you've missed it.
Only a hospice physician — an MD or DO employed or contracted by the hospice — or a nurse practitioner employed or contracted by the hospice. The patient's attending physician cannot conduct the face-to-face unless they are also formally serving as a hospice physician. This is a common error in rural settings where the attending and hospice physician are the same person — the dual role must be explicitly documented in the record.
A hospice RN cannot conduct the face-to-face. A social worker cannot. The discipline isn't a formality — it's a billing requirement.
Two things: a formal face-to-face attestation form, and a clinical narrative. The attestation alone — just a signature and the date — is insufficient. The narrative has to describe what the clinician observed and how those findings support the continued terminal prognosis. It has to be specific to the patient and to the encounter, not a template.
Not defensible:
I conducted a face-to-face encounter on [date]. Patient continues to decline and meets hospice criteria.
Defensible:
Face-to-face encounter conducted [date], 18 days prior to benefit period 4 start [date]. Patient presenting with PPS 30, bedbound, dependent in all ADLs. FAST Stage 7B — patient produced one intelligible word ("no") during the visit. Weight loss of 14% documented over the past 90 days (current 118 lbs, was 137 lbs on [date]). Dysphagia present; family reports patient now declining all solid foods and taking only thickened liquids in small amounts. Clinical assessment is consistent with continued terminal prognosis of six months or less if disease follows expected course. Recertification is clinically supported.
That narrative documents what was seen, references specific measurements from the chart, and explicitly connects the findings to the prognosis. It doesn't leave any gap for an auditor to fill with their own interpretation.
Documented in the visit notes rather than on a formal attestation form. Visit notes don't substitute for the attestation. They can support it, but the formal form — signed by the hospice physician or NP — has to be in the record separately.
Conducted outside the window. Usually because someone calculated from the wrong date or confused the benefit period number.
Completed by the wrong clinician. Attending physician without a documented hospice physician role.
Boilerplate narrative. Generic language that could apply to any patient in any hospice. Auditors flag these immediately.
Conflicting documentation. The face-to-face says PPS 30, and visit notes from the same week document the patient walking to the bathroom. The conflict undermines both documents.
The face-to-face window is narrow enough that it has to be actively tracked. Most agencies miss it because they track recertification due dates but not the 30-day preceding window. The fix is simple: when a patient enters benefit period 2, put the face-to-face window dates on the calendar for BP3 — and for every benefit period after that, set the alert 35 days before the period start. That gives you a 5-day buffer to schedule and complete it before the window closes.
Chart smarter with NotePush
LCD-aligned notes, HOPE tracking, and audit defense — free to try with synthetic patients. No BAA required until you're ready for real patients.